416 related articles for article (PubMed ID: 16628714)
1. Actin polymerization in neutrophils from donors of peripheral blood stem cells: divergent effects of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor.
Carulli G; Mattii L; Azzarà A; Brizzi S; Galimberti S; Zucca A; Benedetti E; Petrini M
Am J Hematol; 2006 May; 81(5):318-23. PubMed ID: 16628714
[TBL] [Abstract][Full Text] [Related]
2. Glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor differently modifies actin polymerization in neutrophils.
Zucca A; Brizzi S; Riccioni R; Azzarà A; Ghimenti M; Carulli G
Clin Ter; 2006; 157(1):19-24. PubMed ID: 16669548
[TBL] [Abstract][Full Text] [Related]
3. Glycosylated or non-glycosylated G-CSF differently influence human granulocyte functions through RhoA.
Mattii L; Azzarà A; Fazzi R; Carulli G; Chimenti M; Cecconi N; Galimberti S; Petrini M
Leuk Res; 2005 Nov; 29(11):1285-92. PubMed ID: 15916805
[TBL] [Abstract][Full Text] [Related]
4. Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: a randomized study in patients undergoing autologous peripheral stem cell transplantation.
Ataergin S; Arpaci F; Turan M; Solchaga L; Cetin T; Ozturk M; Ozet A; Komurcu S; Ozturk B
Am J Hematol; 2008 Aug; 83(8):644-8. PubMed ID: 18508321
[TBL] [Abstract][Full Text] [Related]
5. Superior mobilisation of haematopoietic progenitor cells with glycosylated G-CSF in male but not female unrelated stem cell donors.
Fischer JC; Frick M; Wassmuth R; Platz A; Punzel M; Wernet P
Br J Haematol; 2005 Sep; 130(5):740-6. PubMed ID: 16115131
[TBL] [Abstract][Full Text] [Related]
6. Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used.
Ings SJ; Balsa C; Leverett D; Mackinnon S; Linch DC; Watts MJ
Br J Haematol; 2006 Sep; 134(5):517-25. PubMed ID: 17018030
[TBL] [Abstract][Full Text] [Related]
7. Three types of recombinant human granulocyte colony-stimulating factor have equivalent biological activities in monkeys.
Tanaka H; Tanaka Y; Shinagawa K; Yamagishi Y; Ohtaki K; Asano K
Cytokine; 1997 May; 9(5):360-9. PubMed ID: 9195136
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and adverse events following 5-day repeated administration of lenograstim, a recombinant human granulocyte colony-stimulating factor, in healthy subjects.
Akizuki S; Mizorogi F; Inoue T; Sudo K; Ohnishi A
Bone Marrow Transplant; 2000 Nov; 26(9):939-46. PubMed ID: 11100272
[TBL] [Abstract][Full Text] [Related]
9. CD34+ dose-driven administration of granulocyte colony-stimulating factor after high-dose chemotherapy in lymphoma patients.
Todisco E; Castagna L; Sarina B; Mazza R; Magagnoli M; Balzarotti M; Nozza A; Siracusano L; Timofeeva I; Anastasia A; Demarco M; Santoro A
Eur J Haematol; 2007 Feb; 78(2):111-6. PubMed ID: 17313558
[TBL] [Abstract][Full Text] [Related]
10. Differences in functional activity and antigen expression of granulocytes primed in vivo with filgrastim, lenograstim, or pegfilgrastim.
Ribeiro D; Veldwijk MR; Benner A; Laufs S; Wenz F; Ho AD; Fruehauf S
Transfusion; 2007 Jun; 47(6):969-80. PubMed ID: 17524085
[TBL] [Abstract][Full Text] [Related]
11. Glycosylation of recombinant human granulocyte colony stimulating factor: implications for stability and potency.
Nissen C
Eur J Cancer; 1994; 30A Suppl 3():S12-4. PubMed ID: 7535065
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometry comparison of CD34+ subsets in bone marrow and peripheral blood after priming with glycosylated or non-glycosylated rhG-CSF.
Schiødt I; Knudsen LM; Jensen L; Nikolajsen K; Gaarsdal E; Johnsen HE
Bone Marrow Transplant; 1998 Jun; 21(11):1167-9. PubMed ID: 9645584
[No Abstract] [Full Text] [Related]
13. Effects of glycosylated and non-glycosylated G-CSFs, alone and in combination with other cytokines, on the growth of human progenitor cells.
Pedrazzoli P; Gibelli N; Pavesi L; Preti P; Piolini M; Bertolini F; Robustelli della Cuna G
Anticancer Res; 1996; 16(4A):1781-5. PubMed ID: 8712701
[TBL] [Abstract][Full Text] [Related]
14. Comparison of lenograstim and filgrastim on haematological effects after autologous peripheral blood stem cell transplantation with high-dose chemotherapy.
Kim IH; Park SK; Suh OK; Oh JM
Curr Med Res Opin; 2003; 19(8):753-9. PubMed ID: 14687447
[TBL] [Abstract][Full Text] [Related]
15. Harvesting peripheral blood progenitor cells from healthy donors: retrospective comparison of filgrastim and lenograstim.
Martino M; Console G; Irrera G; Callea I; Condemi A; Dattola A; Messina G; Pontari A; Pucci G; Furlò G; Bresolin G; Iacopino P; Morabito F
J Clin Apher; 2005 Oct; 20(3):129-36. PubMed ID: 15892086
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the potency of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factors in neutropenic and nonneutropenic CD rats.
Nohynek GJ; Plard JP; Wells MY; Zerial A; Roquet F
Cancer Chemother Pharmacol; 1997; 39(3):259-66. PubMed ID: 8996530
[TBL] [Abstract][Full Text] [Related]
17. Effects of recombinant human granulocyte colony-stimulating factor on neutrophil function in normal rats.
Yoshino T; Tamura M; Hattori K; Kawamura A; Imai N; Ono M
Int J Hematol; 1991 Dec; 54(6):455-62. PubMed ID: 1724389
[TBL] [Abstract][Full Text] [Related]
18. Tetraploid myeloid cells in donors of peripheral blood stem cells treated with rhG-CSF.
Kaplinsky C; Trakhtenbrot L; Hardan I; Reichart M; Daniely M; Toren A; Amariglio N; Rechavi G; Izraeli S
Bone Marrow Transplant; 2003 Jul; 32(1):31-4. PubMed ID: 12815475
[TBL] [Abstract][Full Text] [Related]
19. In vivo effects of recombinant human granulocyte colony-stimulating factor on normal neutrophil function and membrane effector molecule expression.
Itoh Y; Kuratsuji T; Tsunawaki S; Aizawa S; Toyama K
Int J Hematol; 1991 Dec; 54(6):463-9. PubMed ID: 1724390
[TBL] [Abstract][Full Text] [Related]
20. [Effect of growth factor on the phenotype of subpopulations and on the kinetics of CD34+ cells in the peripheral blood and in grafts of peripheral stem cells in patients with non-Hodgkin's lymphoma indicated for autologous peripheral blood stem cell transplantation].
Klabusay M; Lysák D; Hrabcáková V; Navrátil M; Coupek P; Mayer J
Cas Lek Cesk; 2008; 147(6):319-24. PubMed ID: 18724529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
